B

Bio-Rad Laboratories

Life science reagents, instruments, software

Vice President – R&D - Molecular Assay Development

Biology & BiotechConfirmed live in the last 24 hours
Full-timeHercules, CA, USA

About the Job

Requirements

  • A master's degree or Ph.D. in Chemistry, Biochemistry, Molecular Biology, Bioengineering, or a related discipline is required.
  • At least 12 years of progressive leadership in IVD/diagnostics R&D, including significant experience leading assay/reagent development organizations and particular depth in molecular platforms such as PCR, digital PCR, isothermal, or sequencing-based methods.
  • A demonstrated track record delivering molecular assays from concept through transfer, including design inputs and outputs, verification and validation, and launch readiness.
  • Deep knowledge of regulated development and quality systems, including FDA QSR, ISO 13485, and IVDR/CE, with inspection and audit readiness expertise.
  • Deep technical fluency in molecular assay chemistries and workflows, including qPCR/dPCR, multiplex PCR, isothermal amplification, NGS library preparation, and nucleic acid extraction.
  • Ability to lead globally distributed, cross-functional teams and influence at the executive level, with strategic, communication, and talent-development skills.
  • Expertise in assay development governance, standards-setting, and design-control strategy, including phase-gate planning, metrics, risk reviews, and compliance strategy across a global, multi-modality program portfolio.
  • Expertise in technology and portfolio strategy, including evaluation and maturation of enabling technologies, build/buy/partner/licensing decisions, and external partnerships across assay modalities.
  • Business acumen, including multi-year investment strategy and P&L trade-off analysis across a global, multi-modality organization.

Responsibilities

  • Set the strategic direction and multi-year investment strategy for the Global Assay Development organization across assay modalities, with particular depth in molecular diagnostics, partnering with Business Unit leaders, Marketing, and Finance to commit R&D investment against growth, margin, and menu-expansion targets.
  • Own the phase-gate governance framework, organization-wide development standards, and analytical and clinical performance bar across assay modalities, setting go/no-go criteria and quality thresholds for Senior Directors and Directors.
  • Serve as the R&D executive sponsor for design-control governance, representing Global Assay Development to Quality/Regulatory leadership and to FDA/IVDR/CE auditors and inspectors on major submissions and inspections.
  • Set the multi-year technology strategy for emerging assay science, deciding where the organization builds proprietary capability versus partners, licenses, or acquires; approve major make/buy/partner and licensing decisions and lead executive-level technical due diligence with Legal/Corporate Development.
  • Own the organization's operating plan, budget, and talent strategy; build and scale technical leadership across modalities; and personally engage on high-risk, high-visibility technical and clinical-readiness decisions with portfolio-wide or company-level risk.
  • Hold peer-level accountability with Systems/Instrument R&D, Manufacturing, Supply Chain, Clinical, Quality, Regulatory, and Commercial leadership to align the integrated systems roadmap and resolve conflicts that cannot be resolved at the program level by Senior Directors.
  • Represent Global Assay Development to the CDG executive team and Bio-Rad leadership, owning the narrative on portfolio health, investment tradeoffs, and risk, and defending resourcing decisions at the executive level.
  • Own competitive and scientific intelligence for the assay portfolio, translating industry, scientific, and IVD-market trends into executive-level recommendations on where to invest, divest, or accelerate.
  • Set relative investment priority and resource allocation across molecular, immunoassay, clinical chemistry, and other assay modalities within the Global Assay Development portfolio, balancing growth, margin, and menu-expansion goals organization-wide.

About the Company

Bio-Rad Laboratories

Life science reagents, instruments, software

Bio-Rad Laboratories, Inc. develops, manufactures, and sells a wide range of tools for life science research and clinical diagnostics, including reagents, instruments, and software. The company serves universities, pharmaceutical and biotech firms, and clinical laboratories, providing products that support cell biology, gene expression, protein purification, and imaging. Its products are sold through a dedicated direct sales force and online channels, with revenue from product sales and service contracts. The company emphasizes quality and reliability in its offerings. The main difference from competitors is its broad, integrated portfolio of end-to-end solutions across research and clinical applications, combined with a global sales and support network. Bio-Rad’s goal is to help researchers and clinicians advance scientific discoveries and improve patient outcomes by enabling accurate experiments and dependable diagnostics.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Hercules, CA
Founded
1952

Recently Posted Jobs

Explore more opportunities at Bio-Rad Laboratories

See more jobs